Create a Free Account
or
Create a Free Account
or
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Key Takeaways:
PPD (NASDAQ:PPD) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.38 by 13.16 per...
Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share...
Funding Will Help Medable Accelerate Drug Development Through Decentralized Clinical Trials PALO ALTO, Calif.--(BUSINESS WIRE)...
Aethlon Medical, Inc. (NASDAQ:AEMD), a company developing medical technology to treat cancer and life-threatening infectious di...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...
Global merger and acquisition activity topped $1 trillion in the second quarter of 2021, with the U.S alone topping $500 billio...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...
